{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:23:09Z","timestamp":1787840589109,"version":"build-2784847793"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Extracorporeal membrane oxygenation (ECMO) is a mode of therapy initiated for patients with cardiac and\/or respiratory failure. Blood transfusion plays a significant role in the management of ECMO patients. In this study, pediatric patients were all cyanotic and transfusion requirements of cyanotic patients differ from other critically ill patients. This study has been conducted to assess the daily transfusion requirements of such group of patients to frame future transfusion policies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>AIMS AND OBJECTIVES:<\/jats:title>\n                    <jats:p>This study was undertaken to assess the daily transfusion requirements of ECMO patients with various indications for ECMO initiation. Our aim was to formulate institutional transfusion policies for paediatric and adult patients on ECMO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>A three years retrospectivTable study was undertaken with 20 study participants. Transfusion requirements were analyzed with regard to the number of days on ECMO support and indications for ECMO initiation. Iatrogenic blood loss\/day was assessed among paediatric age group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Maximum transfusions with PRBC, FFP, and platelet concentrates occurred during the initial 7 days on ECMO. The median packed red cell requirement and FFP requirements for pediatric age group was 1260 ml (IQR = 360-3580) and 900 ml (IQR=150-4650) ml respectively. The median platelet and cryoprecipitate requirements were 450 ml (80-1610) and 120 ml (0.00-600) respectively. The median survival was 8 days (IQR=5.961-10.039).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Transfusion requirements would largely depend upon the clinical status of the patient and therefore, with a smaller number of participants it is difficult to make generalised recommendations. However, the present study could help us to frame institutional-based transfusion support policies for ECMO patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ajts.ajts_52_22","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T15:01:49Z","timestamp":1760799709000},"page":"310-316","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A retrospective study to assess the transfusion requirements of patients on extracorporeal membrane oxygenation support"],"prefix":"10.4103","volume":"19","author":[{"given":"Anila","family":"Mani","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine, Sree Chitra Tirunal Institute for Medical Sciences, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita Radhakrishnan","family":"Nair","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Sree Chitra Tirunal Institute for Medical Sciences, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasish","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Sree Chitra Tirunal Institute for Medical Sciences, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"R1-20251022","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/MAT.0000000000000150","article-title":"Extracorporeal life support:Experience with 2,000 patients","volume":"61","author":"Gray","year":"2015","journal-title":"ASAIO J"},{"key":"R2-20251022","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tmrv.2014.12.001","article-title":"Extracorporeal membrane oxygenation-hemostatic complications","volume":"29","author":"Murphy","year":"2015","journal-title":"Transfus Med Rev"},{"key":"R3-20251022","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1164\/rccm.201609-1945OC","article-title":"Factors associated with bleeding and thrombosis in children receiving extracorporeal membrane oxygenation","volume":"196","author":"Dalton","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-20251022","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0267659112457969","article-title":"Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation","volume":"28","author":"Smith","year":"2013","journal-title":"Perfusion"},{"key":"R5-20251022","first-page":"1","article-title":"ELSOA. Extracorporeal Life Support Organization (ELSO) Anticoagulation Guideline Table","year":"2014","journal-title":"Ann Arbor MI , USA:ELSO"},{"key":"R6-20251022","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.tmrv.2016.07.005","article-title":"Challenges with navigating the precarious hemostatic balance during extracorporeal life support:Implications for coagulation and transfusion management","volume":"30","author":"Andrews","year":"2016","journal-title":"Transfus Med Rev"},{"key":"R7-20251022","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s001340100991","article-title":"Coagulation factor activity during neonatal extra-corporeal membrane oxygenation","volume":"27","author":"Arnold","year":"2001","journal-title":"Intensive Care Med"},{"key":"R8-20251022","first-page":"1","article-title":"Extracorporeal membrane oxygenation:An international Survey","volume":"14","author":"Berkowitz","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"Suppl 1","key":"R9-20251022","doi-asserted-by":"crossref","first-page":"S336","DOI":"10.1111\/jth.12963","article-title":"Extracorporeal life support:The precarious balance of hemostasis","volume":"13","author":"Annich","year":"2015","journal-title":"J Thromb Haemost"},{"key":"R10-20251022","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0022-3476(96)70252-4","article-title":"Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants","volume":"129","author":"Urlesberger","year":"1996","journal-title":"J Pediatr"},{"key":"R11-20251022","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0022-3476(95)70205-9","article-title":"Coagulation factor deficiencies during initiation of extracorporeal membrane oxygenation","volume":"126","author":"McManus","year":"1995","journal-title":"J Pediatr"},{"key":"R12-20251022","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1182\/blood-2015-05-648030","article-title":"Free hemoglobin increases von willebrand factor-mediated platelet adhesion in vitro:Implications for circulatory devices","volume":"126","author":"Da","year":"2015","journal-title":"Blood"},{"key":"R13-20251022","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.athoracsur.2004.06.095","article-title":"Back from irreversibility:Extracorporeal life support for prolonged cardiac arrest","volume":"79","author":"Massetti","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"R14-20251022","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MAT.0b013e3182904a52","article-title":"Extracorporeal life support organization registry report 2012","volume":"59","author":"Paden","year":"2013","journal-title":"ASAIO J"},{"key":"R15-20251022","first-page":"378","article-title":"Enhanced hemolysis in pediatric patients requiring extracorporeal membrane oxygenation and continuous renal replacement therapy","volume":"13","author":"Betrus","year":"2007","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"R16-20251022","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjmed.2013.09.017","article-title":"Impact of more restrictive blood transfusion strategies on clinical outcomes:A meta-analysis and systematic review","volume":"127","author":"Salpeter","year":"2014","journal-title":"Am J Med"},{"key":"R17-20251022","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s00134-004-2352-z","article-title":"Consumption of blood products during mechanical circulatory support in children:Comparison between ECMO and a pulsatile ventricular assist device","volume":"30","author":"Stiller","year":"2004","journal-title":"Intensive Care Med"},{"key":"R18-20251022","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13054-016-1379-1","article-title":"Is the 77.1% rate of in-hospital mortality in patients receiving venoarterial extracorporeal membrane oxygenation really that high?","volume":"20","author":"Shimizu","year":"2016","journal-title":"Crit Care"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_52_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:25:32Z","timestamp":1787837132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_52_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_52_22","relation":{},"ISSN":["0973-6247","1998-3565"],"issn-type":[{"value":"0973-6247","type":"print"},{"value":"1998-3565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"2022-04-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}